Professor of Radiation Oncology, University MD School of Medicine
Radiation Oncology
Dr. Mohan Suntharalingam, MD
|
|
Give Review
Doctor Mohan Suntharalingam, MD is an expert in the field of Radiation Oncology. He went to medical school at Jefferson Medical College. He received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area" and "Top Doctors:Washington-Baltimore". Mohan Suntharalingam is a published doctor. He has 93 publications published. The most current publication "A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck." Mohan Suntharalingam accepts all Medicare patients.
Publications
- Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy.
- State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.
- Long-Term Results of Radiation Therapy Oncology Group 9903: A Randomized Phase 3 Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patie...
- Oropharyngeal cancer (OPC) drives racial outcome disparities in squamous cell carcinoma of the head and neck (HNSCC): Ten year experience at the university of maryland...
- A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of ...
- Response Assessment in Locally Advanced Head and Neck Cancer Based on RECIST and Volume Measurements Using Cone Beam CT Images.
- Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer.
- Response to "What are the best management strategies for radiation- induced xerostomia?"
- The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.
- Modeling Pathologic Response of Esophageal Cancer to Chemoradiation Therapy Using Spatial-Temporal (18)F-FDG PET Features, Clinical Parameters, and Demographics.
- What are the best management strategies for radiation-induced xerostomia?
- Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-Equivalent efficacy, less toxicity, more convenient:...
- Spatial-Temporal (18)FFDG-PET Features for Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiation Therapy.
- WE-C-BRA-01: Best in Physics (Joint Imaging-Therapy) - Modeling Pathologic Response of Locally Advanced Esophageal Cancer to Chemoradiotherapy Using Spatial-Temporal F...
- WE-A-217A-06: Can Pre-Chemoradiotherapy FDG PET/CT Identify Residual Metabolically Active Areas Within Individual Esophageal Tumors?
- Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgi...
- Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definit...
- Dosimetry of source stepping for intravascular brachytherapy.
- Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
- Optimized intensity-modulated arc therapy for prostate cancer treatment.
- Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer.
- Protective role of Bcl2 in metabolic oxidative stress-induced cell death.
- Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
- The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors.
- Radiation therapy for esophageal cancer.
- The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
- Comparison of three treatment options for single brain metastasis from lung cancer.
- Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques.
- P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients.
- Safe pulmonary resection after chemotherapy and high-dose thoracic radiation.
- A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck.
- Divergent changes of flow through individual blood vessels upon localized heating.
- Letter to the editor regarding Wand and Efird IJROBP 25:657-660; 1994.
- Radiotherapy for Merkel cell carcinoma of the skin of the head and neck.
- Combined carboplatin plus bleomycin and conventional radiotherapy for advanced carcinomas of the head and neck.
- Site of urinary tract infection in elderly women admitted to an acute geriatric assessment unit.
- Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging.
- Clinical implementation of intensity-modulated arc therapy.
- Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Th...
- Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors.
- Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive...
- Neoadjuvant Paclitaxel poliglumex, Cisplatin, and radiation for esophageal cancer: a phase 2 trial.
- Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
- Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer.
- Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.
- Squamous cell carcinoma of the esophagus: treat with how many modalities?
- Tomographic image via background subtraction using an x-ray projection image and a priori computed tomography.
- Optimal beam arrangement for stereotactic body radiation therapy delivery in lung tumors.
- Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma.
- Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
- Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer.
- Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
- Do tumors in the lung deform during normal respiration? An image registration investigation.
- Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
- Chemoradiotherapy for esophageal cancer.
- Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy.
- Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
- The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.
- Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
- An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors.
- Globalization of the Radiation Therapy Oncology Group: implementation of a model for service expansion and public health improvement.
- Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.
- Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity.
- Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
- The use of gated and 4D CT imaging in planning for stereotactic body radiation therapy.
- Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein.
- Definitive chemoradiation in the management of locally advanced esophageal cancer.
- Recent advances in radiation therapy for head and neck cancer.
- Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells.
- Promoter methylation and response to chemotherapy and radiation in esophageal cancer.
- Improving patient-specific dosimetry for intravascular brachytherapy.
- An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
- Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
- High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival.
- Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus.
- The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurre...
- Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surg...
- Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
- Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer.
- Management of late distant metastases after trimodality therapy for esophageal cancer.
- Molecular disruption of the MRN(95) complex induces radiation sensitivity in head and neck cancer.
- Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
- Combination radiation and adenovirus-mediated P16(INK4A) gene therapy in a murine model for head and neck cancer.
- The role of concurrent chemotherapy and radiation in the management of patients with squamous cell carcinomas of the head and neck.
- The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study.
- Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.
- Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.
- The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancer.
- Radiotherapy dose perturbation of metallic esophageal stents.
- Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysis.
- Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2.
- Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
Education
-
Jefferson Medical College
Hospital
-
University of Maryland Baltimore Washington Medical Center -
University of Maryland Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568477248 |
| Last Name Of The Provider | SUNTHARALINGAM |
| First Name Of The Provider | MOHAN |
| View All |
Similar Doctors
|
|
Dr. Jack J. Hong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phuoc T. Tran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin J. Redmond, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moody D. Wharam Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael C. Garofalo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danny Y. Song, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lana M. Desouza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda C. Chen, MD |
|
|
Dr. Susannah G. Ellsworth, MD |
|
|
Dr. Alexander S. Engelman, MD |
|
|
Dr. Adam S. Reese, MD |
|
|
Dr. Kruti Patel, MD
This Doctor is OpenDoctor Recommended.
|